The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
Oxford, UK: Genomics plc today announced that it has entered into a collaborative deal with Biogen, Inc., the U.S.-based biotech, to work on multiple sclerosis (MS). Biogen is an international leader in drug therapies for MS, with the broadest MS portfolio in the industry.
Read the rest of entry »
“The Company features alongside The Prime Minister, The Rt Hon Theresa May MP, and a small number of outstanding organisations in the Technology edition”
Blaze, combined with the experience of CTx, makes a powerful and effective platform for lead discovery.
Evotec has made a € 15 M investment to take a minority stake in Exscientia.
LiDia™ Bloodstream Infection (BSI) Test showcased at an Imperial College/Royal Institution Technology vs Infectious Diseases Summit, London
The proposals led by eligible STFC scientists will provide solutions to address the healthcare grand challenges using STFC science, technologies and skills. User engagement is encouraged.
A leading clinician of a top UK children’s hospital believes wireless monitoring is changing the face of healthcare.
Wickham Laboratories Ltd is pleased to announce that we will be on stand 305 at the upcoming Medtec Ireland, held on 4-5 October 2017 at the Radisson Blu Hotel in Galway, Ireland.
Merck Ventures Joins Investment Syndicate and the Board of Macrophage
Oxford Immunotec intends to use the net proceeds from the offering for working capital and general corporate purposes.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, email@example.com, and we will post.